The traditional process for evaluating new therapeutics may not generate the evidence that patients, clinicians, and payers need to make real-world decisions. The volume and complexity of information ...

Real-world evidence (RWE) has emerged as a vital complement to traditional randomised controlled trials by capturing the effectiveness and safety of interventions in routine clinical practice. Drawing ...

We do not conduct studies just to publish; we do so to generate practice‑changing evidence that improves patient outcomes and lives. Yet the journey from study design concept (SDC) to clinical ...

Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...

Industry's first AI-native platform purpose-built for Integrated Evidence Plans and Data Dissemination Plans recognized for setting the standard in biopharma evidence generation Evexa is the ...

Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE) for clinical decision making, today announced a scientific, multi-layered process for ...

Suggested Citation: "3 Opportunities for Real-World Data." National Academies of Sciences, Engineering, and Medicine. 2017. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings ...